CLBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cellebrite DI Ltd (CLBT) is not a good buy at this moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options sentiment is neutral to slightly positive, and there are no significant positive catalysts or recent news to support immediate growth. Additionally, the stock trend analysis predicts a decline in the short and medium term, making it unsuitable for an impatient investor unwilling to wait for optimal entry points.
The MACD is below zero and negatively contracting, indicating bearish momentum. RSI is neutral at 42.303, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Key support is at 12.371, and resistance is at 13.238. Overall, the technical indicators suggest a bearish trend.
Analysts have a Buy rating with a $20 price target from DA Davidson, citing a large and growing addressable market. The company's Q1 results outperformed consensus estimates.
Needham lowered the price target from $18 to $15 due to multiple compression. Technical indicators are bearish, and stock trend analysis predicts a decline of -1.6% in the next day, -1.8% in the next week, and -10.62% in the next month. No recent news or significant trading trends from hedge funds, insiders, or Congress.
Financial data for the latest quarter is unavailable, making it difficult to assess growth trends or profitability.
Analysts maintain a Buy rating, but price targets have been adjusted downward. DA Davidson has a $20 price target, while Needham reduced its target to $15 from $18.
